Name | Glucose transporter type 4 | ||
UniProt ID | GLUT4_HUMAN | ||
Gene Name | SLC2A4 | ||
Gene ID | 6517 | ||
Synonyms |
SLC2A4, GLUT4
|
||
Sequence |
MPSGFQQIGSEDGEPPQQRVTGTLVLAVFSAVLGSLQFGYNIGVINAPQKVIEQSYNETW
LGRQGPEGPSSIPPGTLTTLWALSVAIFSVGGMISSFLIGIISQWLGRKRAMLVNNVLAV LGGSLMGLANAAASYEMLILGRFLIGAYSGLTSGLVPMYVGEIAPTHLRGALGTLNQLAI VIGILIAQVLGLESLLGTASLWPLLLGLTVLPALLQLVLLPFCPESPRYLYIIQNLEGPA RKSLKRLTGWADVSGVLAELKDEKRKLERERPLSLLQLLGSRTHRQPLIIAVVLQLSQQL SGINAVFYYSTSIFETAGVGQPAYATIGAGVVNTVFTLVSVLLVERAGRRTLHLLGLAGM CGCAILMTVALLLLERVPAMSYVSIVAIFGFVAFFEIGPGPIPWFIVAELFSQGPRPAAM AVAGFSNWTSNFIIGMGFQYVAEAMGPYVFLLFAVLLLGFFIFTFLRVPETRGRTFDQIS AAFHRTPSLLEQEVKPSTELEYLGPDEND |
||
Pathway Map | MAP LINK | ||
T.C. Number | 2.A.1.1.80 | ||
KEGG ID | hsa6517 | ||
TTD ID | T67658 | ||
Pfam | PF00083; PF07690 |
Pair Name | Ginsenoside Rb1, Apatinib | |||
Phytochemical | Ginsenoside Rb1 | |||
Drug | Apatinib | |||
Disease Info | [ICD-11: 2B6E] | Hypopharyngeal carcinoma | Investigative | |
Regulate Info | Down-regulation | Glucose transporter type 4 | Expression | |
Result | A combination of apatinib and G-Rb1 induced more tumor cell apoptosis and reduced cell proliferation than the individual drug treatment and promote antitumor immunity by enhancing immunomodulatory molecules. Thus, we believe that this study could serve as a valuable platform to assess the synergetic anticancer effects of the herbal as well as synthetic medicines. |